TCG Opportunity III GP, LLC
CIK 1932445 · last filed 2026-02-12
TCG Opportunity III GP, LLC is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing shows the insider sold $24.3M of TNYA on Feb 12, 2026. Across all open-market trades the lifetime net is +$353.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $41.3M across reported positions. The firm reports its address in San Francisco, CA. 18 SEC filings were submitted jointly with Column Group Opportunity III GP, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$41.27M
4
12
$353.13M
Filer Profile
SUITE DM-900
SAN FRANCISCO, CA 94129
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNYA | 10%+ Owner | 4,253,298 | $0.64 | $2.72M | $38.45M | 3 | 2026-02-12 |
| EIKN | 10%+ Owner | 4,312,139 | $8.94 | $38.55M | $304.96M | 1 | 2026-02-09 |
| Surrozen, Inc./DE (SRZNW) Delisted | 10%+ Owner | 989,893 | $0.00 | $1.5K | $6.27M | 2 | 2026-01-08 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 0 | $1.54 | $0 | $3.45M | 6 | 2024-04-08 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | TNYA | Sell (S) | −35,202,320 | -$24.34M | EDGAR |
| 2026-02-09 | EIKN | Mixed | +45,704,800 | $304.96M | EDGAR |
| 2026-01-08 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +105,700 | $2.10M | EDGAR |
| 2025-12-08 | Surrozen, Inc./DE (SRZNW) Delisted | Buy (P) | +216,900 | $4.17M | EDGAR |
| 2024-04-08 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Mixed | −21,742,413 | $0 | EDGAR |
| 2024-02-14 | TNYA | Buy (P) | +13,333,332 | $60.00M | EDGAR |
| 2023-11-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +45,262 | $31.0K | EDGAR |
| 2023-01-19 | TNYA | Buy (P) | +1,110,906 | $2.79M | EDGAR |
| 2023-01-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +10,756 | $53.2K | EDGAR |
| 2023-01-12 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +618,140 | $2.96M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.